about
Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell CancerStereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With SunitinibGleevec and Gemzar in Patients With Epithelial Ovarian CancerBevacizumab and Lapatinib in Children With Recurrent or Refractory EpendymomaA Study of ENMD-2076 in Ovarian Clear Cell CancersLow Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell CarcinomaMatched Unrelated Donor Transplant for Metastatic Renal Cell CarcinomaEPO906 Therapy in Patients With Advanced Kidney CancerUse of Regorafenib in Recurrent Epithelial Ovarian Cancer
P921
Q54608260-F5FC030E-3F73-4FA5-A6F7-A4FF9202D5A6Q54608261-07994229-F931-49D8-9016-A8612BA3B136Q54608411-B1C71422-6D77-482A-8E39-FDC05AF70553Q54832070-6A95F380-DD19-4CCD-9454-A5C0F2CD7D5CQ54832435-2C7F7354-E348-40A3-98F8-B57FC38E58A5Q54832436-38BF88E7-7DE5-45EC-94BF-8D4883007B27Q54832437-108A247A-04FE-475D-985D-DFFC53BE5B8BQ54832438-CE9D7B63-714E-4B5D-B3AD-4E001F265E22Q54832439-93B03FD4-02A6-47CC-AF7C-65B7BFD39B36Q54872301-659A9FB3-E2FE-4DDE-8E4A-010AB44B1E06Q54881876-BF4CAB30-DF18-42E5-A381-27DCCCCA1543Q54881877-AB7C1188-F12E-4FB0-AF4A-8990F9E07110Q54896893-7E363888-4C41-4F0A-AD9F-2C900EBC953CQ54898648-B7F7C502-1DF9-4519-AD86-AA38146647F8Q54898649-433BA440-BCA7-41F1-A724-6E9DE9C9A85BQ54898650-1704357D-4AC3-4D34-B53E-214B5C22576FQ54898651-407B4B51-9F32-4E70-8B3D-833A5B16CA35Q54898652-93A0DE53-27BC-4B08-9AFF-19E24277FA90Q54899964-1A7C7D3E-9F3B-40A5-B45F-450080C0070CQ54900272-C3CF81AE-80A3-432E-B02E-0FAB125640D6Q54900276-5CEBF2D9-3A32-458A-BCD2-ECCA044FD30FQ54900277-CBE0673D-2046-4FF9-AD7A-79304CE37587Q54907756-303A947E-D20C-4710-926C-565495A7F6D8Q54930880-FB514F47-933F-4DC9-894F-9B06150FEE85Q54931706-6DFE3140-DA0E-48AC-B2E4-7E7CFCDB61C8Q54931735-2BC1045A-6DA4-444B-AE2C-3BE0ACD74F08Q54931736-55A0AC9D-BEDB-4EDE-82FA-4FC6554DBEB0Q54931748-6494EF85-69F4-4313-8FFE-134EAAFF9C74Q54931749-955ACB88-FD88-4595-AB28-3EF7981CD330Q54931750-F75A2DAD-D732-4D1D-A900-BCFA34D46348Q54931751-5C6A2E94-B3E6-43BD-B971-34CB335DCF03Q54931752-D70E59BD-5F2B-4032-BE1E-B1AF543C7BB1Q54936886-0D594806-2D90-43B2-B195-7071F39DE879Q54936913-1752F031-DBC9-437B-97DD-FF33478AC90DQ54937024-04BD3F54-0EC9-4038-B220-B47FF4AE3165Q54937026-B3F54777-8F31-4093-BDA7-175CB30BA6DAQ54937027-6881E0ED-6ACA-4BD2-94FF-D4A61CA7ADE4Q54937031-84BB9123-677D-4A97-83F6-2B83E6B52947Q54937039-C44CC74D-DEAE-4846-B396-7CEA1EF82D4DQ54950664-495BBFD1-A799-4F18-B883-089CC7707FF1
P5166
Q64121053-6BBDC2CE-84E9-4E00-A15C-B00F5CE106E4Q64220765-1C3A525C-C069-480E-9E2A-5F512AD4AF40Q64350427-816CB5B7-1E4F-4170-88F5-5505EA4D4383Q64673886-F950965B-C706-45E5-9A36-3A0B2BD1BF67Q64679346-2B502AAA-F363-41A2-AC2D-52B1A00E534AQ65361187-F787FD43-9132-499B-99BF-E4AF2FBC4222Q65379539-1FCCA33A-17DE-4471-BD09-323B82F3475DQ65390684-A539E71E-C705-4368-9EB9-20394C84CB56Q66038841-542068C5-EEE7-43DA-B478-DE292F8BED41Q66406077-77A9029B-42A7-41B3-A8B5-691B7B61DDCD
P921
description
Human disease
@en
Krankheit
@de
مرض يصيب الإنسان
@ar
name
ovarian clear cell adenocarcinoma
@en
type
label
ovarian clear cell adenocarcinoma
@en
altLabel
Clear cell adenocarcinoma of the ovary
@en
Ovarian Clear Cell Adenocarcinoma
@en
clear cell adenocarcinoma of ovary
@en
ovary clear cell adenocarcinoma
@en
prefLabel
ovarian clear cell adenocarcinoma
@en
P2888
P1550
P1748
P2892
P31
P5270
MONDO:0006045